Author Login IJIRT Partner Network (IPN) Login

Precision medicine approach to discover the effective therapy for Hydroxychloroquine No respondents in COVID-19

  • Unique Paper ID: 155020
  • Volume: 8
  • Issue: 12
  • PageNo: 1228-1229
  • Abstract:
  • The world is gearing up to battle against the Coronavirus disease 19 (COVID-19) outbreak which has already led to more than 323,256 deaths and 4,893,186 confirmed cases globally as on May 22, 2020 [1]. There are currently no drugs licensed for the treatment or prevention of COVID-19. While several drug trials are ongoing, advisories were published on the use of hydroxychloroquine as prophylaxis for SARS-CoV-2 infection [2-4]. The existence of hydroxychloroquine failure was even recorded in many cases [5] and that is to be suggested for the resistance developed.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 8
  • Issue: 12
  • PageNo: 1228-1229

Precision medicine approach to discover the effective therapy for Hydroxychloroquine No respondents in COVID-19

Related Articles

30 Mar, 2022

Fabrication and Characterization of Vegetal face pack for Laudative Corium

Read More
Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry